Tracer Pharma is a quality contract manufacturer of active pharmaceutical ingredients and intermediates for use in radiopharmaceutical products within nuclear medicines. Our products help in the diagnosis and treatment of diseases by improving patient outcomes.

We work according to GMP standards and our small scale development and manufacturing set up is ideal for specific customer needs or custom made solutions. We are able to respond fast and flexible to your demands and are committed to customer satisfaction.


We have developed a complete quality system according to GMP standards for our manufacturing processes. Our latest GMP Certificate issued by the Danish Medicines Agency (DMA), and we are included in the list (Registered Companies) of manufacturers of APIs for use in human medicinal products. We are inspected on a regular basis and are fully compliant with demands according to approved marketing authorizations.


Our dedicated staff is highly trained and experienced from working many years in the biotech and pharmaceutical industry. We have expertise in research & development, manufacturing, QA & QC and supply chain management.

Upon request we can provide a full breakdown of educational backgrounds and work experiences.


Tracer Pharma is born out of the development work and manufacturing of active pharmaceutical ingredients (APIs) and intermediates performed at the Technical University of Denmark (DTU) and Risø National Laboratory during more than 20 years. Since 1991 we have collaborated with Mallinckrodt Pharmaceuticals (Now Curium Pharma) with the aim to develop and manufacture quality products for the use within nuclear medicine.

Tracer Pharma was formed at the end of 2011 as an independent private company.